Novartis extends operations at U.K. plant for another year, keeping some 200 workers on board
As Novartis shifts away from the production of older, less profitable drugs, the drugmaker has placed a slew of production facilities in the cost-cutting crosshairs. But with the company facing increased demand for two unnamed products, one plant is set to keep on churning through next year. More than 200 Novartis manufacturing workers will keep their jobs for… Read More »
